Trammell Crow Company (TCC) has closed on the land that will be used to build Fulton Labs, a 423,454-square-foot facility that is being developed to help solve chronic lab space shortage throughout the Chicago region.
The 1.3-acre plot of land that TCC purchased is located at 400 N. Aberdeen Street in Chicago’s vibrant Fulton Market neighborhood. The company expects to break ground on the innovative life science facility in July. CBRE is marketing the project for lease.
“We are excited to take this next step and move forward in creating a new center designed for innovation and collaboration among life science companies,” said Johnny Carlson, principal of TCC’s Midwest business unit.
The Fulton Labs facility will span 16 floors, with 12 floors of wet or dry lab space, dependent on the tenant’s needs. The building is designed to offer researchers flexibility, scalability and innovation, with features such as a column-free and long-span layouts. Further, all lab spaces are designed to meet VC-A vibration criteria, an important step for enabling reproducible results.
“With Fulton Labs’ advanced R&D infrastructure, flexible lab spaces, and full-floor launchpad for early stage companies, we are confident that this facility will help to promote growth in the Midwest’s life science industry,” said Grady Hamilton, managing director of TCC’s Midwest business unit.